COVID-19 and Pediatric Cardiomyopathy

In response to the coronavirus COVID-19 crisis, many families affected by cardiomyopathy are concerned about the health of their children and are taking special precautions to protect the health of every family member. The Children's Cardiomyopathy Foundation (CCF) is committed to providing support and reliable information during this time of crisis.

General Guidelines

We are still learning about the risk of this novel virus to children with cardiomyopathy. Based on available research and feedback from leading children's hospitals and academic medical centers, the coronavirus does not seem to affect children as seriously as adults. There have been a few reported cases of children with "pediatric multi-system inflammatory syndrome," which is believed to be linked to COVID-19. This condition appears to be rare and needs to be studied more in depth.

While most children with COVID-19 may have no or mild symptoms, it is not known whether children with heart disease or children with heart transplants are at an increased risk. Therefore, family members should continue to take all health precautions as outlined by the Centers for Disease Control and Prevention (CDC). Recommendations include:

  • Seek reputable sources of information on COVID-19. Trustworthy resources are listed below.
  • Speak to your/your child's cardiologist for medical advice specific to your child and family.
  • Prevent transmission: avoid touching your face (eyes, nose, mouth), wash your hands frequently for 20 seconds with warm water and antibacterial soap, and clean and disinfect frequently touched surfaces.
  • Practice social distancing: avoid unnecessary travel and high traffic public places or gatherings with large numbers of people.
  • Avoid close contact with people who may seem sick. Practice covering coughs and sneezes with a tissue or use the inside of your elbow.
  • Use a mask or face covering as directed by your state's health department/Centers for Disease Control.

CCF Webinars on COVID-19

COVID-19 Updates for Cardiomyopathy Families
Daphne Hsu, M.D., Division Chief of Pediatric Cardiology
Neha Bansal, M.D., Assistant Professor of Pediatrics
Children's Hospital at Montefiore
June 4, 2020

Register for the webinar

Emotional Considerations for Pediatric Cardiomyopathy Families
During COVID-19 and Beyond

Debra Lefkowitz, PsyD., Assistant Professor of Clinical Psychology in Psychiatry
Children’s Hospital of Philadelphia (Philadelphia, PA)
May 13, 2020

View recording

COVID-19 and Pediatric Cardiomyopathy: Information and Updates
Daphne Hsu, M.D., Division Chief of Pediatric Cardiology
Margaret Aldrich, M.D., Director of Infection Control
Children's Hospital at Montefiore
March 31, 2020

View recording

COVID-19 Survey for Pediatric Cardiomyopathy Families

The Children's Cardiomyopathy Foundation (CCF) and its medical advisors have developed a 5-minute survey to learn about who is being impacted in the pediatric cardiomyopathy community and to understand the severity of the impact of COVID-19.

Families are encouraged to take the survey if their child meets the following two criteria:

  • Is diagnosed with cardiomyopathy (includes children who have received a transplant)
  • Has experienced symptoms of COVID-19 in the last three months

Survey findings will be shared with physicians to assist them with developing COVID-19 screening and treatment guidelines. The survey is anonymous, and families are encouraged to complete the survey online.

A report of current findings can be found on CCF Connect. New data will be analyzed as it becomes available.

National Institutes of Health Study

It was announced on May 4, 2020 that the National Institutes of Health (NIH) is launching a national study, to determine the infection rate of COVID-19 in children and how the disease manifests. The Human Epidemiology and Response to SARS-CoV-2 (HEROS) study will recruit 6,000 children from 2,000 families in 11 cities across the U.S. Children and their families enrolled in the study will be followed for six months to understand who becomes infected and who develops symptoms. View news release.

Rare Diseases Clinical Research Network Survey

A new online survey launched by the National Institutes of Health supported Rare Disease Clinical Research Network aims to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and caregivers. Results will help shed light on the needs of people with rare disease during the pandemic. For more information on the RDCRN COVID-19 survey, including how to participate, click here.

COVID-19 Information and Resources

Centers for Disease Control and Prevention
American Heart Association
American College of Cardiology
Medications and COVID-19
Advanced Cardiac Therapies Improving Outcomes Network (ACTION)
American Academies of Pediatrics: Congenital Heart Public Health Consortium
American Academy of Pediatrics: Parenting Website
Coronavirus.gov
National Institutes of Health

Coping Resources

Centers for Disease Control and Prevention: Stress and Coping
Centers for Disease Control and Prevention: Helping Children Cope with Emergencies
Covibook: Coloring Book for Kids
Mental Health and COVID-19
National Alliance on Mental Health: COVID 19 Resource and Information Guide

This page will be updated as more information and resources become available.

CCF also regularly updates a COVID-19 forum with news updates, research findings, and additional resource links. The forum is located on CCF Connect, CCF's private online community for registered members. To register with CCF, please click here.

 

Stay Informed
Keep current on PCM research and CCF happenings in our Heart to Heart newsletter.
Unite and Fight
Connect with hundreds of other families struggling with this disease through our online member community.
Shop for a Cure
Shop for CCF merchandise to support our research and education efforts.
The Children's Cardiomyopathy Foundation is a 501 (c)(3) non-profit recognized by the U.S. Internal Revenue Service.
© 2020 Children's Cardiomyopathy Foundation. All rights reserved.